About Medi-Caps
Medi-Caps is a company based in Indore (India) founded in 1983. The company has 9 employees. Medi-Caps offers products and services including Empty Hard Gelatine Capsules. Medi-Caps operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Indore, India
- Employees 9
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website medicaps.com
- Social Facebook
- Legal Name Medi-Caps Ltd.
- Annual Revenue₹28.21 Cr
FY 2025 · +1% YoY
- Net Loss-₹57.1 Lakh
FY 2025 · -2% margin
- EBITDA₹90.2 Lakh
FY 2025 · 3% margin
- Employee Count9
Associated legal entities of Medi-Caps
Medi-Caps operates through Medicaps Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medicaps Limited Listed CIN L70100MP1983PLC002231 | Active | 06 Aug 1983 | Indore, Madhya Pradesh | ₹28.2 Cr | 2 | 7 | View details |
Products & Services of Medi-Caps
Medi-Caps offers a comprehensive portfolio of products and services, including Empty Hard Gelatine Capsules.
Manufactured capsules for enclosing pharmaceutical ingredients securely.
Board of directors of Medicaps Limited (Medi-Caps)
Medicaps Limited is the primary company behind Medi-Caps. The board of Medicaps Limited currently have 6 directors; the longest-serving is Ramesh Chandra Mittal, appointed in 1983. 17 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Chandra Mittal DIN 00035272 | Director | 06 Aug 1983 | 43 yrs 2 mo | Medicaps Limited |
| Kusum Mittal DIN 00035356 | Director | 04 May 1991 | 35 yrs 5 mo | Medicaps Limited |
| Alok K Garg DIN 00274321 | Managing Director | 01 Apr 2007 | 19 yrs 6 mo | Medicaps Limited |
| Ashok Agrawal Omprakash DIN 07870578 | Director | 25 Jul 2017 | 9 yrs 2 mo | Medicaps Limited |
| Dharmendra Solanki DIN 09055239 | Director | 05 Feb 2021 | 5 yrs 8 mo | Medicaps Limited |
| Gajendra Singh DIN 10253991 | Director | 11 Aug 2023 | 3 yrs 2 mo | Medicaps Limited |
People of Medi-Caps
1 people are tracked at Medi-Caps (1 in leadership); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Gayathri V | Managing Director | Leadership |
Complete people profiles for Medi-Caps
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Medi-Caps
Medi-Caps is a publicly listed company on the BSE with ticker symbol MEDICAPQ in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Oct 1987
- Listed onBSE: 523144
- Listed entityMedi-Caps Ltd.
- Exchange sectorHealth technology
- ISININE442D01010
- Share price₹30.94 (-1.31% on the day) · 2026-05-11
- Market capitalisation₹39.1 Cr
- EPS (diluted, trailing year)₹-3.50
- Volume (last session)3,271
- Analyst consensusNo rating
Financials of Medi-Caps
Figures of Medicaps Limited, the primary company behind Medi-Caps, for FY 2025. Revenue was ₹28.21 Cr (+1% year on year). Net loss was -₹57.1 Lakh (-2% margin). EBITDA was ₹90.2 Lakh (3% margin). Revenue has grown at a compounded annual rate of -27% over three years and -9% over five years.
- ₹28.21 CrRevenue · FY 2025 · +1% YoY
- -₹57.1 LakhNet loss · -2% margin
- ₹90.2 LakhEBITDA · 3% margin
- ₹12.47 CrPaid-up capital
- 2Employees (provident fund records)
- -27%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹12.4 Cr | -₹3.0 Cr | -₹9.4 Cr |
| 2024 | ₹25.4 Cr | -₹0.6 Cr | -₹1.8 Cr |
| 2023 | ₹27.3 Cr | -₹2.2 Cr | -₹0.1 Cr |
| 2022 | ₹49.4 Cr | ₹1.8 Cr | ₹5.4 Cr |
| 2021 | ₹68.3 Cr | ₹10.1 Cr | ₹8.7 Cr |
Balance sheet, profit and loss, cash flow and ratios of Medicaps Limited are on its company page.
Detailed financial statements for Medi-Caps
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Medi-Caps
Medi-Caps operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| zelgen.com | 2009 | Suzhou, China | $61.92M | – | Company developing small molecules & eukaryotic cell based recombinant protein drugs | |
| capsugel.com | 1875 | Morristown, United States | – | – | Dosage forms are delivered for preclinical, clinical, and commercial supply. | |
| adarepharmasolutions.com | 2015 | Lawrence Township, United States | – | 217 | CDMO manufacturing solid drugs | |
| cpc.com | 1971 | Hauppauge, United States | – | 27 | Product development, manufacturing and packaging services | |
| lotuspharm.com | 1966 | Taipei, Taiwan | – | – | Contract manufacturing for oral solid formulations is offered. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | – | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | |
| vovantis.com | 2008 | Vadodara, India | – | 145 | Develops and manufactures novel effervescent drug delivery systems. | |
| glukembiocare.com | 2014 | Hyderabad, India | – | 234 | Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. |
Detailed competitors of Medi-Caps
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medi-Caps
The website of Medi-Caps (medicaps.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 23.7% vs previous month
Similar companies to Medi-Caps
10 companies that operate in the same segment as Medi-Caps (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medi-Caps
Medi-Caps was founded in 1983.
Medi-Caps is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.
Medi-Caps has 9 employees.
The primary company behind Medi-Caps, Medicaps Limited, reported revenue of ₹28.21 Cr for FY 2025, up 1% year on year.
Medi-Caps was established in 1983 in Indore, India, as a manufacturer of empty hard gelatin capsules within the pharmaceutical sector. Capsules are produced in six sizes, ranging from 00 to 4, with printing services available. Novel developments include Pearlz Capsules featuring metallic coloring, Python Printing techniques, and Li-Fill Caps. Operations focus on capsule production and customization for industry needs.
Medi-Caps's top competitors include Inventia Healthcare, Zim Labs and Lotus.
Medi-Caps offers Empty Hard Gelatine Capsules.
Yes, Medi-Caps is publicly traded on BSE under the ticker symbol MEDICAPQ.
Medi-Caps operates through Medicaps Limited.
The legal entities of Medi-Caps currently have 7 directors, including Alok K Garg, Ramesh Chandra Mittal, Ashok Agrawal Omprakash and others.